Paul M. Watt

2.9k citations

50 papers · 2.4k indexed · h-index 20

Molecular Biology top 5%
Oncology top 10%
Cancer Research top 10%
Plant Science top 10%
Immunology top 10%

Co-authors: Ian D. Hickson Rhona H. Borts Edward J. Louis Greg White Barbara J. Holt Patrick G. Holt Ursula R. Kees Paul R. Caron
Topics: Cancer-related gene regulation (7 papers)DNA Repair Mechanisms (6 papers)RNA Interference and Gene Delivery (6 papers)
Cited by: Molecular Biology Toxicology Aging
Journals: Cell Nucleic Acids Research Journal of Biological Chemistry
Partner nations: Australia United Kingdom United States

In The Last Decade

Paul M. Watt

50 papers receiving 2.3k citations

Peers

Countries citing papers authored by Paul M. Watt

Since Specialization

Citations

This map shows the geographic impact of Paul M. Watt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Watt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Watt more than expected).

Fields of papers citing papers by Paul M. Watt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Watt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Watt. The network helps show where Paul M. Watt may publish in the future.

Co-authorship network of co-authors of Paul M. Watt

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Watt. A scholar is included among the top collaborators of Paul M. Watt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Watt. Paul M. Watt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Target identification for small-molecule discovery in the FOXO3a tumor-suppressor pathway using a biodiverse peptide library 2021 ·Cell chemical biology ·(unknown),(unknown),(unknown),(unknown),Paul M. Watt,(unknown),Vikrant Kumar,(unknown),(unknown),(unknown),(unknown),(unknown),Kavitha Bharatham,(unknown),T.K. Prasad,(unknown),Markus K. Muellner,Miguel B. Coelho,C Torrance,Grahame J. McKenzie,Ashok R. Venkitaraman	8
2	Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers 2018 ·Oncogene ·Edina Wang,Anabel Sorolla,(unknown),(unknown),Samuel J. Beck,Emily Golden,Robert E. Dewhurst,Laura V. Flórez,Mark N. Cruickshank,Katrin Hoffmann,R.M. Hopkins,Jonghwan Kim,Andrew J. Woo,Paul M. Watt,Pilar Blancafort	67
3	GFP-complementation assay to detect functional CPP and protein delivery into living cells 2015 ·Scientific Reports ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Shane R. Stone,(unknown),Tatjana Heinrich,Karen M. Kroeger,Yew‐Foon Tan,Katrin Hoffmann,Wayne R. Thomas,Paul M. Watt,R.M. Hopkins	61
4	Target validation of the inosine monophosphate dehydrogenase (IMPDH) gene in Cryptosporidium using Phylomer® peptides 2014 ·Experimental Parasitology ·(unknown),Rongchang Yang,(unknown),(unknown),(unknown),(unknown),T. P. Armstrong,R.M. Hopkins,Paul M. Watt,Simon Reid,A. Armson,Una Ryan	17
5	The Neuroprotective Efficacy of Cell-Penetrating Peptides TAT, Penetratin, Arg-9, and Pep-1 in Glutamic Acid, Kainic Acid, and In Vitro Ischemia Injury Models Using Primary Cortical Neuronal Cultures 2013 ·Cellular and Molecular Neurobiology ·Bruno P. Meloni,(unknown),(unknown),R.M. Hopkins,Paul M. Watt,Neville W. Knuckey	61
6	A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor 2013 ·The International Journal of Biochemistry & Cell Biology ·Kevin R. W. Ngoei,Bruno Catimel,(unknown),Paul M. Watt,Marie A. Bogoyevitch	10
7	The Construction of “Phylomer” Peptide Libraries as a Rich Source of Potent Inhibitors of Protein/Protein Interactions 2012 ·Methods in molecular biology ·(unknown),Paul M. Watt	6
8	Lack of Neuroprotection of Inhibitory Peptides Targeting Jun/JNK after Transient Focal Cerebral Ischemia in Spontaneously Hypertensive Rats 2011 ·Journal of Cerebral Blood Flow & Metabolism ·(unknown),(unknown),(unknown),Paul M. Watt,(unknown),Neville W. Knuckey,Bruno P. Meloni	13
9	AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid 2010 ·Brain Research ·(unknown),Bruno P. Meloni,Frank Mastaglia,Paul M. Watt,Neville W. Knuckey	17
10	MEIS proteins as partners of the TLX1/HOX11 oncoprotein 2009 ·Leukemia Research ·(unknown),Nicholas G. Gottardo,Jette Ford,D.N. D’Souza,Wayne K. Greene,Ursula R. Kees,Paul M. Watt	8
11	Pyrrhocoricin as a potential drug delivery vehicle for Cryptosporidium parvum 2008 ·Experimental Parasitology ·(unknown),(unknown),Una Ryan,Paul M. Watt,R.M. Hopkins,Simon Reid,A. Armson	7
12	Reverse Two-hybrid Screening Identifies Residues of JNK Required for Interaction with the Kinase Interaction Motif of JNK-interacting Protein-1 2004 ·Journal of Biological Chemistry ·Renae K. Barr,R.M. Hopkins,Paul M. Watt,Marie A. Bogoyevitch	23
13	The Critical Features and the Mechanism of Inhibition of a Kinase Interaction Motif-based Peptide Inhibitor of JNK 2004 ·Journal of Biological Chemistry ·Renae K. Barr,Ingrid Boehm,Paul V. Attwood,Paul M. Watt,Marie A. Bogoyevitch	54
14	Deletion of one copy of the p16INK4A tumor suppressor gene is implicated as a predisposing factor in pediatric leukemia 2004 ·Biochemical and Biophysical Research Communications ·(unknown),(unknown),Nicholas G. Gottardo,David L. Baker,Ursula R. Kees,Paul M. Watt	4
15	Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG) 2003 ·Leukemia ·Ursula R. Kees,Nyla A. Heerema,(unknown),Paul M. Watt,David L. Baker,(unknown),Fatih M. Uckun,Harland N. Sather	55
16	Enforced expression of HOX11 is associated with an immature phenotype in J2E erythroid cells 2002 ·British Journal of Haematology ·Wayne K. Greene,Jette Ford,(unknown),Peta A. Tilbrook,Paul M. Watt,S. Peter Klinken,Ursula R. Kees	13
17	Sif2p interacts with the Sir4p amino-terminal domain and antagonizes telomeric silencing in yeast 1998 ·Current Biology ·Moira Cockell,Hubert Renauld,Paul M. Watt,Susan M. Gasser	32
18	Genome stability: Failure to unwind causes cancer 1996 ·Current Biology ·Paul M. Watt,Ian D. Hickson	31
19	The C-Terminal Domain of Saccharomyces cerevisiae DNA Topoisomerase II 1994 ·Molecular and Cellular Biology ·Paul R. Caron,Paul M. Watt,James C. Wang	18
20	Negative regulation of the human embryonic globin genes zeta and epsilon. 1989 ·PubMed ·Peter Lamb,Paul M. Watt,Nicholas Proudfoot	4

About Paul M. Watt

Paul M. Watt is a scholar working on Molecular Biology, Parasitology and Hematology, having authored 50 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer-related gene regulation (7 papers), DNA Repair Mechanisms (6 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Toxicology (89 citations) and Aging (45 citations). Paul M. Watt has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Ian D. Hickson, Rhona H. Borts, Edward J. Louis, Greg White, Barbara J. Holt, Patrick G. Holt, Ursula R. Kees, Paul R. Caron, R.M. Hopkins and J C Wang. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact